|
1
|
Wilson VG: Growth and differentiation of
HaCaT Ketatinocytes. Methods Mol Biol. 1195:33–41. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Coperchini F, Leporati P, Rotondi M and
Chiovato L: Expanding the therapeutic spectrum of metformin: From
diabetes to cancer. J Endocrinol Invest. 38:1047–1055. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Radhakrishnan P, Dabelsteen S, Madsen FB,
Francavilla C, Kopp KL, Steentoft C, Vakhrushev SY, Olsen JV,
Hansen L, Bennett EP, et al: Immature truncated O-glycophenotype of
cancer directly induces oncogenic features. Proc Natl Acad Sci USA.
111:pp. E4066–E4075. 2014; View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Viollet B, Guigas B, Sanz Garcia N,
Leclerc J, Foretz M and Andreelli F: Cellular and molecular
mechanisms of metformin: an overview. Clin Sci (Lond). 122:253–270.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Malaguarnera R, Sacco A, Morcavallo A,
Squatrito S, Migliaccio A, Morrione A, Maggiolini M and Belfiore A:
Metformin inhibits androgen-induced IGF-IR upregulation in prostate
cancer cells by disrupting membrane-initiated androgen signaling.
Endocrinology. 155:1207–1221. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fasih A, Elbaz HA, Hüttemann M, Konski AA
and Zielske SP: Radiosensitization of Pancreatic cancer cells by
metformin through the AMPK pathway. Radiat Res. 182:50–59. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tebbe C, Chhina J, Dar SA, Sarigiannis K,
Giri S, Munkarah AR and Rattan R: Metformin limits the adipocyte
tumor-promoting effect on ovarian cancer. Oncotarget. 5:4746–4764.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Han G, Gong H, Wang Y, Guo S and Liu K:
AMPK/mTOR-mediated inhibition of survivin partly contributes to
metformin-induced apoptosis in human gastric cancer cell. Cancer
Biol Ther. 16:77–87. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gandini S, Puntoni M, Heckman-Stoddard BM,
Dunn BK, Ford L, DeCensi A and Szabo E: Metformin and cancer risk
and mortality: A systematic review and meta-analysis taking into
account biases and confounders. Cancer Prev Res (Phila). 7:867–885.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Viollet B, Guigas B, Sanz Garcia N,
Leclerc J, Foretz M and Andreelli F: Cellular and molecular
mechanisms of metformin: an overview. Clin Sci (Lond). 122:253–270.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Momtazi AA, Derosa G, Maffioli P, Banach M
and Sahebkar A: Role of microRNAs in the therapeutic effects of
curcumin in non-cancer diseases. Mol Diagn Ther. 20:335–345. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cao DD, Li L and Chan WY: MicroRNAs: Key
regulators in the central nervous system and their implication in
neurological diseases. Int J Mol Sci. 17:E8422016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cao Y, Xu R, Xu X, Zhou Y, Cui L and He X:
Down-regulation of lncRNA CASC2 by microRNA-21 increases the
proliferation and migration of renal cell carcinoma cells. Mol Med
Rep. 14:1019–1025. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu YR, Qi HJ, Deng DF, Luo YY and Yang SL:
MicroRNA-21 promotes cell proliferation, migration, and resistance
to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal
cancer. Tumour Biol. 37:12061–12070. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang W, Yang Y, Xia L, Yang Y, Wang F,
Song M, Chen X, Liu J, Song Y, Zhao Y and Yang C: MiR-221 promotes
capan-2 pancreatic ductal adenocarcinoma cells proliferation by
targeting PTEN-Akt. Cell Physiol Biochem. 38:2366–2374. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang Y, Yang YB, Zhang XH, Yu XL, Wang ZB
and Cheng XC: MicroRNA-21 gene and cancer. Med Oncol. 30:3762013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jian H, Wang J, Wang T, Wei L, Li J and
Liu L: Identification of rapeseed MicroRNAs involved in early stage
seed germination under salt and drought stresses. Front Plant Sci.
7:6582016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guedes JR, Santana I, Cunha C, Duro D,
Almeida MR, Cardoso AM, de Lima MC and Cardoso AL: MicroRNA
deregulation and chemotaxis and phagocytosis impairment in
Alzheimer's disease. Alzheimers Dement (Amst). 12:7–17. 2015.
|
|
20
|
Sun H, Wang P, Zhang Q, He X, Zai G, Wang
X, Ma M and Sun X1: MicroRNA21 expression is associated with the
clinical features of patients with gastric carcinoma and affects
the proliferation, invasion and migration of gastric cancer cells
by regulating Noxa. Mol Med Rep. 13:2701–2707. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cao J, Liu J, Xu R, Zhu X, Liu L and Zhao
X: MicroRNA-21 stimulates epithelial-to-mesenchymal transition and
tumorigenesis in clear cell renal cells. Mol Med Rep. 13:75–82.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu RH, Ning B, Ma XE, Gong WM and Jia TH:
Regulatory roles of microRNA-21 in fibrosis through interaction
with diverse pathways (Review). Mol Med Rep. 13:2359–2366. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang F, Wang Y, Xue J, Ma Q, Zhang J, Chen
YF, Shang ZZ, Li QQ, Zhang SL and Zhao L: Effect of Corilagin on
the miR-21/smad7/ERK signaling pathway in a schistosomiasis-induced
hepatic fibrosis mouse model. Parasitol Int. 65:308–315. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mima K, Nishihara R, Yang J, Dou R, Masugi
Y, Shi Y, da Silva A, Cao Y, Song M, Nowak J, et al: MicroRNA MIR21
(miR-21) and PTGS2 Expression in Colorectal Cancer and Patient
Survival. Clin Cancer Res. 22:3841–3848. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee JT, Shan J, Zhong J, Li M, Zhou B,
Zhou A, Parsons R and Gu W: RFP-mediated ubiquitination of PTEN
modulates its effect on AKT activation. Cell Res. 23:552–564. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Soares HP, Ni Y, Kisfalvi K, Sinnett-Smith
J and Rozengurt E: Different patterns of Akt and ERK feedback
activation in response to rapamycin, active-site mTOR inhibitors
and metformin in pancreatic cancer cells. PLoS One. 8:e572892013.
View Article : Google Scholar : PubMed/NCBI
|
